Setting ambitious targets for surveillance and treatment rates among patients with hepatitis C related cirrhosis impacts the cost-effectiveness of hepatocellular cancer surveillanc...

by Jennifer Uyei, Tamar H Taddei, David E Kaplan, Michael Chapko, Elizabeth R Stevens, R Scott Braithwaite
Published 2019-01-01

The Patient-Provider Relationship Is Associated with Hepatitis C Treatment Eligibility: A Prospective Mixed-Methods Cohort Study.

by Shari S Rogal, Robert M Arnold, Michael Chapko, Barbara V Hanusa, Ada Youk, Galen E Switzer, Mary Ann Sevick, Nichole K Bayliss, Carolyn L Zook, Alexis Chidi, David S Obrosky, Susan L Zickmund
Published 2016-01-01